MMBG Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701K Sell
14,630
-2,940
-17% -$126K 0.06% 121
2026
Q1
$667K Sell
17,570
-12,185
-41% -$577K 0.06% 121
2025
Q4
$1.51M Sell
29,755
-1,877
-6% -$96K 0.13% 86
2025
Q3
$1.76M Sell
31,632
-1,630
-5% -$95.4K 0.16% 73
2025
Q2
$2.3M Buy
33,262
+3,277
+11% +$223K 0.23% 58
2025
Q1
$2.12M Buy
29,985
+12,320
+70% +$1.02M 0.24% 60
2024
Q4
$1.52M Buy
+17,665
New +$1.91M 0.16% 72

Other funds holding NVO

MMBG Investment Advisors's NVO Position: Q2 2026 in Review

MMBG Investment Advisors reduced its Novo Nordisk (NVO) stake by 17% in Q2 2026, selling an estimated $126K and leaving 14,630 shares worth $701K. The position accounts for 0.06% of the portfolio, ranked #121.

MMBG Investment Advisors first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.3M in Q2 2025. 960 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MMBG Investment Advisors held 14,630 shares of Novo Nordisk worth $701K as of Q2 2026.
  • MMBG Investment Advisors sold 2,940 Novo Nordisk shares in Q2 2026, an estimated $126K.
  • Novo Nordisk made up 0.06% of MMBG Investment Advisors's portfolio in Q2 2026, its #121 holding.
  • MMBG Investment Advisors first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • MMBG Investment Advisors's Novo Nordisk position peaked at $2.3M in Q2 2025.
  • 960 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.